|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S3
|
$600,000
|
$30,000
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S4
|
$75,000
|
$3,750
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
X-ray/Fluorescence Molecular and Diffuse Optical Tomography of Glioma
|
5K25CA138578-04
|
$186,392
|
$186,392
|
Leblond, Frederic
|
DARTMOUTH COLLEGE
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-04
|
$1,492,676
|
$179,121
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-04S1
|
$74,993
|
$8,999
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-04S2
|
$149,680
|
$17,962
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-28
|
$607,994
|
$6,080
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-22S1
|
$139,963
|
$1,400
|
Hackney, Mary
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
5U10CA052784-22
|
$399,112
|
$3,991
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Vascular targeted pan PI-3 kinase inhibitor prodrug, SF1126 for glioma therapy
|
5R01CA094233-09
|
$268,308
|
$268,308
|
DURDEN, DONALD
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
|
Validation of PROMIS Measures in Children with Brain Tumors
|
1R01CA174452-01
|
$331,803
|
$331,803
|
LAI, JIN-SHEI
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Validation of microRNA Targets in Glioma
|
5R01CA138734-03
|
$351,692
|
$351,692
|
Krichevsky, Anna
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
|
1P01CA154291-01A1
|
$1,651,535
|
$1,304,713
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S3
|
$4,555,705
|
$91,114
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S4
|
$74,854
|
$1,497
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S5
|
$139,989
|
$2,800
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Utilizing proteoglycan biology to develop a novel treatment for brain cancers
|
1F31CA168198-01
|
$31,217
|
$31,217
|
Raman, Karthik
|
UNIVERSITY OF UTAH
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035119-28
|
$820,953
|
$8,210
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
2P30CA046592-24
|
$5,694,947
|
$170,848
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-24S1
|
$49,948
|
$1,498
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-24S2
|
$74,872
|
$2,246
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Understanding Mechanisms of Resistance to Anti-angiogenic Treatments
|
1R01CA160216-01A1
|
$325,626
|
$325,626
|
ARBAB, ALI
|
HENRY FORD HEALTH SYSTEM
|
|
Understanding and Eliminating Oncogenic EGFR Signaling in Malignant Glioma
|
5U01CA141556-04
|
$660,126
|
$660,126
|
Charest, Alain
|
TUFTS MEDICAL CENTER
|
|
Ultrasound-assisted convection-enhanced drug delivery to the brain
|
1R21CA164935-01
|
$206,155
|
$206,155
|
Olbricht, William
|
CORNELL UNIVERSITY
|
|
Two Compartment Models to Improve Brain Tumor Therapy
|
5R01CA137488-18
|
$459,957
|
$459,957
|
NEUWELT, EDWARD
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
|
TWIST1 as a target for inhibition of glioma invasion
|
5R01CA136808-02
|
$344,450
|
$344,450
|
ROSTOMILY, ROBERT
|
UNIVERSITY OF WASHINGTON
|
|
Tumor-cell-specific targets for combined hyperthermia and radiation effects
|
5R01CA154320-03
|
$319,944
|
$79,986
|
Pandita, Tej
|
UNIV OF TX SW MED CTR-DALLAS
|
|
TUMOR RADIOSENSITIZATION USING A NITRIC-OXIDE-NEUTRAL, TUNABLE OXYGEN-BINDING PRO
|
2R44CA138006-05
|
$1,000,000
|
$1,000,000
|
SHAH, AJIT
|
OMNIOX, INC.
|
|
TUMOR RADIOSENSITIZATION USING A NITRIC-OXIDE-NEUTRAL, TUNABLE OXYGEN-BINDING PRO
|
5R44CA138006-04
|
$949,265
|
$949,265
|
SHAH, AJIT
|
OMNIOX, INC.
|
|
Tumor Penetrating Peptides for Cancer Targeting
|
5R01CA152327-02
|
$396,325
|
$396,325
|
RUOSLAHTI, ERKKI
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
Tumor Microenvironment in Cancer Progression
|
ZIABC011332
|
$343,873
|
$34,387
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Tumor heterogeneity in breast cancer brain metastasis after brain radiation
|
ZIABC011330
|
$155,509
|
$77,755
|
Smart, DeeDee
|
CCR (NCI)
|
|
Tumor Cell Networks Center
|
5U54CA112967-08
|
$2,356,288
|
$117,814
|
Lauffenburger, Douglas
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Tumor Cell Biology Training Program
|
2T32CA009056-36A1
|
$392,736
|
$196,368
|
WU, HONG
|
UNIVERSITY OF CALIFORNIA AT LOS ANGELES
|
|
Tulane Medical/Cancer Center Minority-Based Community Clinical Oncology Program
|
1U10CA167782-01
|
$700,000
|
$14,000
|
ROBINSON, WILLIAM
|
TULANE UNIVERSITY OF LOUISIANA
|
|
TSPO Ligands for Cancer Imaging
|
1R01CA163806-01A1
|
$452,739
|
$452,739
|
MANNING, Henry
|
VANDERBILT UNIVERSITY MED CTR
|
|
Tryptophan Metabolism in Human Brain Tumors
|
5R01CA123451-05
|
$291,850
|
$291,850
|
JUHASZ, CSABA
|
WAYNE STATE UNIVERSITY
|
|
Translation of smart contrast agents for brain tumor characterization by MR
|
5R01CA140102-03
|
$350,246
|
$350,246
|
Hyder, Dewan Syed
|
YALE UNIVERSITY
|
|
Transgenic in vivo delivery of MDA7/IL24 for maligannt glioma therapy
|
5R01CA129489-05
|
$341,162
|
$341,162
|
GERMANO, ISABELLE
|
MOUNT SINAI SCHOOL OF MEDICINE
|
|
Transcriptional regulation of gliomagenesis
|
5R01CA157933-02
|
$327,850
|
$327,850
|
HUANG, SUYUN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Training Program in Translational Brain Tumor Research
|
5T32CA151022-03
|
$238,033
|
$238,033
|
Pieper, Russell
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
Training Program in Nervous System Tumors
|
5K12CA090354-12
|
$764,863
|
$764,863
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Toward a molecular classification of human gliomas
|
5R01CA057683-19
|
$301,819
|
$301,819
|
LOUIS, DAVID
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Topic 301, Pharmaco-Kinesis Corporation Phase I entitled "A VEGF Nanosensor to Mo
|
N43CO120036-000
|
$170,009
|
$170,009
|
CURRELI, MARCO
|
PHARMACO-KINESIS CORPORATION
|
|
Tools for detecting biologically important sequence variation in cancer
|
5R21CA152432-02
|
$113,673
|
$113,673
|
KARCHIN, RACHEL
|
JOHNS HOPKINS UNIVERSITY
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035415-29
|
$700,123
|
$7,001
|
MOWAT, REX
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
|
TNF Signaling and Cell Death
|
ZIASC010376
|
$785,953
|
$550,167
|
Liu, Zheng-Gang
|
CCR (NCI)
|
|
Therapeutic Opportunities for Pediatric Astrocytoma
|
5P01CA142536-02
|
$1,633,391
|
$1,633,391
|
SEGAL, ROSALIND
|
DANA-FARBER CANCER INSTITUTE
|
|
Therapeutic approaches that target cancer cell metabolism
|
5K23CA120862-05
|
$137,295
|
$41,189
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
The UT MD Anderson Cancer Center Community Clinical Oncology Program Research Bas
|
2U10CA045809-24
|
$1,389,595
|
$83,376
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
Total relevant funding to Brain for this search: $171,301,440
|